BeiGene and Springworks Therapeutics are Collaborating to Research a Combination Therapy for Advanced Solid Tumours
stevepb / Pixabay

BeiGene and Springworks Therapeutics are Collaborating to Research a Combination Therapy for Advanced Solid Tumours

The companies BeiGene Ltd. and SpringWorks Therapeutics have announced that they will collaborate to research the safety and preliminary efficacy of a combination of two drugs: BeiGene’s investigational drug lifirafenib…

Continue Reading BeiGene and Springworks Therapeutics are Collaborating to Research a Combination Therapy for Advanced Solid Tumours
Multiple Studies Help Define New Biomarkers for Myelodysplastic Syndromes
luvqs / Pixabay

Multiple Studies Help Define New Biomarkers for Myelodysplastic Syndromes

According to a story from Medpage Today, three recent research studies have managed to reveal new biomarkers for myelodysplastic syndromes. Biomarkers are a crucial factor for understanding a medical condition…

Continue Reading Multiple Studies Help Define New Biomarkers for Myelodysplastic Syndromes
A Supplemental New Drug Application Has Been Submitted for a Potential Treatment of Immune Thrombocytopenia
jarmoluk / Pixabay

A Supplemental New Drug Application Has Been Submitted for a Potential Treatment of Immune Thrombocytopenia

Dova Pharmaceutics has submitted a supplemental New Drug Application to the US FDA on behalf of Doptelet® (avatrombopag), which is being researched as an investigational treatment of immune thrombocytopenia in…

Continue Reading A Supplemental New Drug Application Has Been Submitted for a Potential Treatment of Immune Thrombocytopenia

A Study of Huntington’s Disease in Mice Suggests an ‘Early Stage’ of the Condition

A recent study using mice suggests that Huntington’s disease may begin to show symptoms early on in life. For more detailed information, you can read the source article here, at…

Continue Reading A Study of Huntington’s Disease in Mice Suggests an ‘Early Stage’ of the Condition
Close Menu